Cyclooxygenase in biology and disease - PubMed (original) (raw)
Review
. 1998 Sep;12(12):1063-73.
Affiliations
- PMID: 9737710
Free article
Review
Cyclooxygenase in biology and disease
R N Dubois et al. FASEB J. 1998 Sep.
Free article
Abstract
Cyclooxygenase (COX), the key enzyme required for the conversion of arachidonic acid to prostaglandins was first identified over 20 years ago. Drugs, like aspirin, that inhibit cyclooxygenase activity have been available to the public for about 100 years. In the past decade, however, more progress has been made in understanding the role of cyclooxygenase enzymes in biology and disease than at any other time in history. Two cyclooxygenase isoforms have been identified and are referred to as COX-1 and COX-2. Under many circumstances the COX-1 enzyme is produced constitutively (i.e., gastric mucosa) whereas COX-2 is inducible (i.e., sites of inflammation). Here, we summarize the current understanding of the role of cyclooxygenase-1 and -2 in different physiological situations and disease processes ranging from inflammation to cancer. We have attempted to include all of the most relevant material in the field, but due to the rapid progress in this area of research we apologize that certain recent findings may have been left out.
Comment in
- From molecular analysis to medical practice: recent studies reveal new therapeutic targets for an old medicine.
Marchesi VT. Marchesi VT. FASEB J. 1998 Sep;12(12):1061. doi: 10.1096/fasebj.12.12.1061. FASEB J. 1998. PMID: 9737709 No abstract available.
Similar articles
- Cyclooxygenase-2: a therapeutic target.
Turini ME, DuBois RN. Turini ME, et al. Annu Rev Med. 2002;53:35-57. doi: 10.1146/annurev.med.53.082901.103952. Annu Rev Med. 2002. PMID: 11818462 Review. - Regulation of cyclo-oxygenase-2.
Stack E, DuBois RN. Stack E, et al. Best Pract Res Clin Gastroenterol. 2001 Oct;15(5):787-800. doi: 10.1053/bega.2001.0235. Best Pract Res Clin Gastroenterol. 2001. PMID: 11566041 Review. - Distribution of COX-1 and COX-2 in normal and inflamed tissues.
Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Isakson P. Seibert K, et al. Adv Exp Med Biol. 1997;400A:167-70. doi: 10.1007/978-1-4615-5325-0_24. Adv Exp Med Biol. 1997. PMID: 9547553 - Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors.
Kulkarni SK, Jain NK, Singh A. Kulkarni SK, et al. Methods Find Exp Clin Pharmacol. 2000 Jun;22(5):291-8. doi: 10.1358/mf.2000.22.5.796648. Methods Find Exp Clin Pharmacol. 2000. PMID: 11031730 Review. - Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A, Ottani A, Sandrini M. Bertolini A, et al. Pharmacol Res. 2001 Dec;44(6):437-50. doi: 10.1006/phrs.2001.0872. Pharmacol Res. 2001. PMID: 11735348 Review.
Cited by
- Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets.
Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, Hu J, Fleming I, Wang DW. Wang B, et al. Signal Transduct Target Ther. 2021 Feb 26;6(1):94. doi: 10.1038/s41392-020-00443-w. Signal Transduct Target Ther. 2021. PMID: 33637672 Free PMC article. Review. - Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.
Kontoghiorghes GJ, Kontoghiorghe CN. Kontoghiorghes GJ, et al. Cells. 2020 Jun 12;9(6):1456. doi: 10.3390/cells9061456. Cells. 2020. PMID: 32545424 Free PMC article. Review. - Urinary PGE-M: a promising cancer biomarker.
Wang D, DuBois RN. Wang D, et al. Cancer Prev Res (Phila). 2013 Jun;6(6):507-10. doi: 10.1158/1940-6207.CAPR-13-0153. Epub 2013 May 1. Cancer Prev Res (Phila). 2013. PMID: 23636051 Free PMC article. - Cyclooxygenase Inhibition Alters Proliferative, Migratory, and Invasive Properties of Human Glioblastoma Cells In Vitro.
Ferreira MT, Miyake JA, Gomes RN, Feitoza F, Stevannato PB, da Cunha AS, Serachi FO, Panagopoulos AT, Colquhoun A. Ferreira MT, et al. Int J Mol Sci. 2021 Apr 21;22(9):4297. doi: 10.3390/ijms22094297. Int J Mol Sci. 2021. PMID: 33919029 Free PMC article. - Efficacy of cyclo-oxygenase inhibition by two commercially available firocoxib products in horses.
Barton MH, Paske E, Norton N, King D, Giguère S, Budsberg S. Barton MH, et al. Equine Vet J. 2014 Jan;46(1):72-5. doi: 10.1111/evj.12095. Epub 2013 Jul 16. Equine Vet J. 2014. PMID: 23662599 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous